| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |